| 引用本文:刘倩，李永娟，赵俊精，刘国通，韩叙，刘永香.穴位埋线配合质子泵抑制剂治疗慢性非萎缩性胃炎的疗效观察[J].世界中医药,2019,(07):. |
|
| 穴位埋线配合质子泵抑制剂治疗慢性非萎缩性胃炎的疗效观察 |
| Observation on the Efficacy of Acupoint Catgut Embedding Combined with Proton Pump Inhibitor in Chronic Non-atrophic Gastritis |
| 投稿时间：2018-12-02 |
| DOI：10.3969/j.issn.1673-7202.2019.07.057 |
| 中文关键词: 慢性非萎缩性胃炎 质子泵抑制剂 穴位埋线 临床疗效 |
| English Keywords:Chronic non-atrophic gastritis Proton pump inhibitor Acupoint catgut embedding Clinical efficacy |
| 基金项目:廊坊市科技支撑计划项目（2016013172） |
|
| 摘要点击次数: 558 |
| 全文下载次数: 583 |
| 中文摘要: |
| 目的：探究穴位埋线法与质子泵抑制剂相配合治疗慢性非萎缩性胃炎的临床疗效。方法：选取2016年1月至2018年12月廊坊市人民医院收治的慢性非萎缩性胃炎患者200例作为研究对象，按照随机数字表法随机分为对照组和观察组，每组100例。对照组患者给予奥美拉唑肠溶片口服治疗，观察组给予奥美拉唑肠溶片口服联合穴位埋线治疗。观察并分析2组的治疗效果。结果：观察组总有效率89%，对照组总有效率67%，观察组的症状治愈率明显高于对照组，2组比较差异有统计学意义(P<0.05)。观察组内镜治疗总有效率为88.00%，对照组为77%，2组比较差异有统计学意义（P<0.05）。观察组不良反应发生率为13.00%(13/100)，对照组为8.00%(8/100)，组间比较差异无统计学意义（P>0.05)。结论：穴位埋线与质子泵抑制剂相配合治疗慢性非萎缩性胃炎的疗效显著，治愈率较高，症状得到了较好的改善。 |
| English Summary: |
| To explore the clinical efficacy of acupoint catgut embedding combined with proton pump inhibitors in the treatment of chronic non-atrophic gastritis.Methods：A total of 200 patients with chronic non-atrophic gastritis admitted to Langfang People's Hospital from January 2016 to December 2018 were selected as the research objects.They were randomly divided into control group and observation group with 100 cases in each group by random number table method.The control group was treated with omeprazole enteric-coated tablets orally,while the observation group was treated with omeprazole enteric-coated tablets orally combined with acupoint catgut embedding.The therapeutic effects of the 2 groups were observed and analyzed.Results：The total effective rate was 89% in the observation group and 67% in the control group.The cure rate of symptoms in the observation group was significantly higher than that in the control group.There was a significant difference between the 2 groups(P<0.05).Comparedtheefficacy of therapeutic endoscopy,the total effective rate was 88.00% in the observation group and 77% in the control group.There was significant difference between the 2 groups(P<0.05).Observed the side effects,the incidence of side effects was 13.00% in the observation group and 8.00% in the control group.There was no significant difference between the 2 groups(P>0.05).Conclusion：Acupoint catgut embedding combined with proton pump inhibitor is effective in treating chronic non-atrophic gastritis,with a higher cure rate and better improvement of symptoms. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
